Vaccine Scheduler
Norway: Recommended vaccinations
| General recommendation | |
| Recommendation for specific groups only | |
| Catch-up (e.g. if previous doses missed) | |
| Vaccination not funded by the National Health system | |
| Mandatory vaccination |
| Birth | Weeks | Months | Years | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4 | 6 | 3 | 5 | 12 | 15 | 7 | 11 | 12 | 15 | 18 | |||||
| Coronavirus disease (COVID-19) | COVID-191 | ||||||||||||||
| RSV | RSV2 | ||||||||||||||
| tuberculosis | BCG3 | ||||||||||||||
| rotavirus infection | RV1 | RV1 | |||||||||||||
| diphtheria | D | D | D | D | d | ||||||||||
| tetanus | TT | TT | TT | TT | TT | ||||||||||
| pertussis | acP | acP | acP | acP | acP | ||||||||||
| poliomyelitis | IPV | IPV | IPV | IPV | IPV | ||||||||||
| Haemophilus influenzae type b infection | Hib | Hib | Hib | ||||||||||||
| hepatitis B | HepB4 | HepB5 | HepB | HepB | HepB | ||||||||||
| pneumococcal disease | PCV13 | PCV13 | PCV13 | PCV20 or PCV21 and PPSV236 | |||||||||||
| measles | MEAS | MEAS | |||||||||||||
| mumps | MUMPS | MUMPS | |||||||||||||
| rubella | RUBE | RUBE | |||||||||||||
| human papillomavirus infection | HPV2 (F/M)7 | ||||||||||||||
| influenza | IIV3/aIIV38 | ||||||||||||||
Version:
Footnotes:
- https://www.fhi.no/en/va/vaccines-for-adults/vaccines-in-the-adult-immunisation-programme/vaccines-in-the-adult-immunisation-programme/covid-19-vaccine---information-for-the-public/
- RSV-vaccine is recommended in pregnancy, but not part of the national vaccination program and costs are not covered.
- Specific at-risk groups only
- Babies of mothers with hepatitis B. Birth dose and HB immunoglobulin should be given within 24 hours of birth.
- Babies of mothers with hepatitis B. Second vaccine dose is given at age 4 weeks. These infants thereafter follow the national vaccination programme.
- Fully funded for patients with HIV infections, stem cell transplantations and for anatomical or functional asplenia. Partly funded when turning 65 years. Not funded (NF) for other risk groups. More information: https://www.fhi.no/en/va/vaccines-for-adults/vaccines-in-the-adult-immunisation-programme/vaccines-in-the-adult-immunisation-programme/pneumococcal-vaccine-information-for-the-public/
- Gender-neutral (boys and girls) vaccination offered in schools (seventh grade). Bivalent vaccine.
- https://www.fhi.no/en/va/vaccines-for-adults/vaccines-in-the-adult-immunisation-programme/vaccines-in-the-adult-immunisation-programme/the-influenza-vaccine---information-for-the-public/
More information available at:
https://www.fhi.no/en/va/childhood-immunisation-programme
All vaccines offered through the Norwegian childhood vaccination program are free of charge.
MAJOR HISTORICAL CHANGES
2006: DTaP at 7 years added to the immunization program in January 2006
2007: Pneumococcal conjugate vaccine added to the childhood immunization program in July 2006
2009: HPV vaccine introduced in the immunization program for 12 year old girls in autumn 2009
2009: BCG at 13-15 years discontinued; starting from autumn 2009 BCG is given only to children at birth in defined risk groups
2011: Prevenar 13 replaced Prevenar in April 2011
2013: TdacP at 15 years added to the immunization program in autumn 2013
2014: Rotavirus introduction (2 doses) for all children born from 01 Sept. 2014
2017: Hepatitis B vaccine introduced as part of the Childhood Immunisation Programme for all children born after November 1st 2016.
2018: Gender-neutral HPV vaccination
2024: Maternal vaccination against pertussis (week 24 of pregnancy)
Date of last update: 04 February 2026.